C. Benosman, Control of the dynamics of chronic myeloid leukemia by imatinib, 2010.

L. Berezansky, S. Bunimovich-mendrazitsky, and A. Domoshnitsky, A mathematical model with time-varying delays in the combined treatment of chronic myeloid leukemia, Advances in Difference Equations, vol.2012, issue.1, pp.257-266, 2012.
DOI : 10.1124/pr.55.3.4

C. I. Chen, H. T. Maecker, and P. P. Lee, Development and dynamics of robust T-cell responses to CML under imatinib treatment, Blood, vol.111, issue.11, pp.5342-5349, 2008.
DOI : 10.1182/blood-2007-12-128397

J. Cortes, M. Talpaz, S. O-'brien, D. Jones, and R. Luthra, Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate, Clinical Cancer Research, vol.11, issue.9, pp.3425-3432, 2005.
DOI : 10.1158/1078-0432.CCR-04-2139

R. Deconde, P. S. Kim, D. Levy, and P. P. Lee, Post-transplantation dynamics of the immune response to chronic myelogenous leukemia, Journal of Theoretical Biology, vol.236, issue.1, pp.39-59, 2005.
DOI : 10.1016/j.jtbi.2005.02.015

M. Delitala, T. Lorenzi, and M. Melensi, A Structured Population Model of Competition Between Cancer Cells and T Cells Under Immunotherapy, Mathematical Models of Tumor-Immune System Dynamics 107, Proceedings in Mathematics & Statistics, pp.47-58, 2014.

R. Eftimie, J. L. Bramson, and D. J. Earn, Interactions Between the Immune System and Cancer: A??Brief Review of??Non-spatial Mathematical Models, Bulletin of Mathematical Biology, vol.39, issue.5, pp.2-32, 2011.
DOI : 10.1002/eji.200839152

L. Gollmann, D. Kern, and H. Maurer, Optimal control problems with control and state delays and applications to growth processes, IIASA Symposium on " Applications of Dynamic Systems to Economic Growth with Environment, 2008.

L. Gollmann, D. Kern, and H. Maurer, Optimal control problems with delays in state and control variables subject to mixed control-state constraints, Optimal Control Applications and Methods, vol.76, issue.5, pp.341-365, 2009.
DOI : 10.1002/oca.843

L. Gollmann and H. Maurer, Theory and applications of optimal control problems with multiple time-delays, Journal of Industrial and Management Optimization, vol.102, pp.413-441, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00916554

S. Gottschalk, N. Anderson, and C. Hainz, Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells, Clinical Cancer Research, vol.10, issue.19, pp.6661-6668, 2004.
DOI : 10.1158/1078-0432.CCR-04-0039
URL : http://clincancerres.aacrjournals.org/content/clincanres/10/19/6661.full.pdf

P. S. Kim, P. P. Lee, and D. Levy, Dynamics and Potential Impact of the Immune Response to Chronic Myelogenous Leukemia, PLoS Computational Biology, vol.17, issue.6, p.1000, 2008.
DOI : 10.1371/journal.pcbi.1000095.t018

S. J. Lee, Chronic myelogenous leukemia, Br. J. Haematol, vol.111, issue.4, pp.993-1009, 2000.

M. C. Mackey, C. Ou, L. Pujo-menjouet, and J. Wu, Periodic Oscillations of Blood Cell Populations in Chronic Myelogenous Leukemia, SIAM Journal on Mathematical Analysis, vol.38, issue.1, pp.166-187, 2006.
DOI : 10.1137/04061578X

S. Marley and M. Gordon, Chronic myeloid leukemia:stem cell derived but progenitor cell driven, Clinical Sciences, vol.109, pp.13-25, 2006.

H. Moore and N. K. Li, A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction, Journal of Theoretical Biology, vol.227, issue.4, pp.513-523, 2004.
DOI : 10.1016/j.jtbi.2003.11.024

S. Nanda and R. Lg, B cell chronic lymphocytic leukemia - A model with immune response, Discrete and Continuous Dynamical Systems - Series B, vol.18, issue.4, pp.1053-1076
DOI : 10.3934/dcdsb.2013.18.1053
URL : http://www.aimsciences.org/journals/doIpChk.jsp?paperID=8277&mode=full

B. Neiman, A mathematical model of chronic myelogenous leukaemia, 2002.

M. M. Peet, P. S. Kim, S. I. Niculescu, and D. Levy, New Computational Tools for Modeling Chronic Myelogenous Leukemia, Mathematical Modelling of Natural Phenomena, vol.47, issue.2, pp.119-139, 2009.
DOI : 10.1007/s00285-003-0211-0
URL : http://www.mmnp-journal.org/articles/mmnp/pdf/2009/02/mmnp20092p119.pdf

I. R. Radulescu, D. Candea, and A. Halanay, A study on stability and medical implications for a complex delay model for CML with cell competition and treatment, Journal of Theoretical Biology, vol.363, pp.30-40, 2014.
DOI : 10.1016/j.jtbi.2014.08.009

I. R. Radulescu, D. Candea, and A. Halanay, A control delay differential equations model of evolution of normal and leukemic cell populations under treatment, IFIP Advances in Information and Communication Technology, pp.257-266, 2014.

C. Riether, C. M. Schurch, and A. F. Ochsenbein, Regulation of hematopoietic and leukemic stem cells by the immune system, Cell Death and Differentiation, vol.133, issue.2, pp.187-198, 2015.
DOI : 10.1002/ijc.28198

S. Topalian, . Weiner, . Gj, . Pardoll, and . Dm, Cancer Immunotherapy Comes of Age, Journal of Clinical Oncology, vol.29, issue.36, pp.4828-4836, 2011.
DOI : 10.1200/JCO.2011.38.0899